Original Article

Construction of an Adenovirus Vaccine Expressing the Cross-reactive Antigen AMA1 for Neospora caninum and Toxoplasma gondii and Its Immune Response in an Animal Model


Background: We aimed to construct an adenovirus expressing a cross-reactive fragment of the apical membrane antigen 1 (AMA1) antigen and evaluated the concomitant immune response in BABL/c mice, allowing protection against N. caninum and T. gondii infection.

Methods: The study was conducted in Agricultural College of Yanbian University, Yanji, Jilin, China In 2015-2016. Primers were designed using the AMA1 gene sequences of N. caninum (AB265823.1) and T. gondii (AF010264.1). After linearization of the plasmid ADV4-NcAMA1 and the framework plasmid pacAd5, a total of 293T cells were co-transfected and Ad5-NcAMA1 recombinant adenovirus were packed. BALB/c mice were inoculated. Simultaneously serum IgG antibody levels and IFN-γand IL-4 cytokine levels were determined by ELISA. After immunization three times in two weeks, each group of BABL/c mice were divided into two groups, respectively given intraperitoneal inoculation by the Neospora tachyzoite and Toxoplasma tachyzoite. Then we observed the clinical symptoms and statistical survival rate of mice.

Results: The level of IgG in BABL/c mice immunized with Ad5-NcAMA1 was significantly increased when compared with that of pVAX1-NcAMA1 and PBS groups (P<0.01). At the same time, the cytokine levels of IFN-γ and IL-4 were also higher in the Ad4-NcAMA1 group than in the control groups (P<0.01). Moreover, BABL/c mice immunized with Ad5-NcAMA1, pVAX1-NcAMA1, and PBS showed survival rates of 75%, 45% and 20% after N. caninum infection, and 45%, 10% and 0% after T. gondii infection, respectively.

Conclusion: The adenovirus vaccineAd5-NcAMA1 could provide protective immunity against N. caninum and T. gondii infection.

Klauck V, Machado G, Pazinato R et al. Relation between Neospora caninum and abortion in dairy cows: Risk factors and pathogenesis of disease. Microb Pathog. 2016; 92:46-49.

Oh J, Lee SH, Lee SJ et al. Detection of Antibodies against Toxoplasma gondii in Cattle Raised in Gyeongbuk Province, Korea. J Food Prot. 2016; 79(5):821-824.

Machačová T, Ajzenberg D, Žákovská A et al. Toxoplasma gondii and Neospora caninum in wild small mammals: Seroprevalence, DNA detection and genotyping. Vet Para-sitol. 2016; 223:88-90.

Wilson DJ, Orsel K, Wadding J,Rajeev M, Sweeny AR, Joseph T, Grigg ME, Raverty SA. Neospora caninum is the leading cause of bovine fetal loss in British Columbia, Can-ada. Vet Parasitol. 2016; 218: 46-51.

Moore D, Reichel M, Spath E, Campero C. Neospora caninum causes severe economic losses in cattle in the humid pampa region of Argentina. Trop Anim Health Prod. 2013; 45(5):1237-1241.

Graham DA, Calvert V, Whyte M, Marks J. Absence of serological evidence forhuman Neospora caninum infection. Vet Rec. 1999; 144: 672-673.

Zhang G, Huang X, Boldbaatar D et al. Construction of Neospora caninum stably ex-pressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice. Vaccine. 2010; 28(45):7243-7247.

Tingting Sun, Jingshun Jin, Lijun Jia. Clon-ing of cross antigen AMA1 gene between Neospora caninum and Toxoplasma gondii and construction of prokaryotic expression vector (J). J Agri Sci Yanbian University. 2015; 37(1):8-11.

Zhang H, Compaore MK, Lee EG et al. Apical membrane antigen 1 is a cross-reactive antigen between Neospora caninum and Toxoplasma gondii, and the anti-NcAMA1 antibody inhibits host cell inva-sion by both parasites. Mol Biochem Para-sitol. 2007; 151(2):205-212.

Jia LJ, Zhang SF, Liu MM et al. Isolation, Identification, and Pathogenicity of Neospo-ra caninum China Yanbian strain. Iran J Par-asitol. 2014; 9(3): 394-401.

Zhang C, Liu HM, Li QW et al. Construc-tion of recombinant adenovirus vector containing hBMP2 and hVEGF165 genes and its expression in rabbit Bone marrow mesenchymal stem cells. Tissue Cell. 2014; 46(5):311-317.

Lijun Jia, Shoufa Zhang, Cheng Lu. Solu-ble antigens analyses of Neospora caninum and establishemnt of indirect ELISA. Chinese J Vet Med. 2009; 45(9):25-26.

Krishna R, Xia D, Sanderson S et al. A large-scale proteogenomics study of apicomplexan pathogens-Toxoplasma gondii and Neospora caninum. Proteomics. 2015;15(15):2618-2628.

Brasil AW, Parentoni RN, Feitosa TF et al. Risk factors for Toxoplasma gondii and Ne-ospora caninum seropositivity in buffaloes in Paraiba State, Brazil. Rev Bras Parasitol Vet. 2015; 24(4):459-463.

Zhang H, Nishikawa Y, Yamagishi J et al. Neospora caninum: application of apical membrane antigen 1 encapsulated in the oligomannose-coated liposomes for re-duction of offspring mortality from infec-tion in BALB/c mice. Exp Parasitol. 2010; 125(2):130-136.

Tonkin ML, Crawford J, Lebrun ML, Boulanger MJ. Babesia divergens and Ne-ospora caninum apical membrane antigen 1 structures reveal selectivity and plasticity in apicomplexan parasite host cell invasion. Protein Sci. 2013; 22(1):114-127.

Suhua Wang. Adenoviral vector and its application in gene therapy (J). China An-imal Husbandry & Veterinary Medicine. 2009; 36 (9):119-121.

Otaki M, Jiang DP, Sasayama M et al. Generation of recombinant adenovirus expressing siRNA against the L mRNA of measles virus and subacute sclerosing panencephalitis virus. Microbiol Immunol. 2007; 51(10):985-991.

Liddell S, Parker C, Vinyard B et al. Im-munization of mice with plasmid DNA coding for NcGRA7 or NcsHSP33 con-fers partial protection against vertical transmission of Neospora caninum. J Parasi-tol. 2003; 89(3): 496-500.

Naserifar R, Ghaffarifar F, Dalimi A et al. Evaluation of Immunogenicity of Cocktail DNA Vaccine Containing Plasmids En-coding Complete GRA5, SAG1, and ROP2 Antigens of Toxoplasma gondii in BALB/C Mice. Iran J Parasitol. 2015; 10(4):590-598.

Jenkins M, Parker C, Tuo W et al. Inclu-sion of CpG adjuvant with plasmid DNA coding for NcGRA7 improves protection against congenital neosporosis. Infect Immun. 2004; 72(3): 1817-1819.

Nishikawa Y, Ikeda H, Fukumoto S et al. Immunization of dogs with a canine her-pesvirus vector expressing Neospora caninum surface protein, NcSRS2. Int J Parasitol. 2000; 30(11): 1167-1171.

Nishikawa Y, Inoue N, Xuan X et al. Pro-tective efficacy of vaccination by recombi-nant vaccinia virus against Neospora cani-numin fection. Vaccine. 2001; 19(11-12):1381-1390.

Lijun JIA, Shoufa Zhang. Construction of adenovirous vaccine expressing the anti-gen SAG1 of Neospora caninum and its im-mune response in animal modle(J). Scientia Agricultura Sinica. 2012; 45(22):4705-4712.

Yu L, Yamagishi J, Zhang S et al. Protec-tive effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressingTgAMA1 as vac-cines against Toxoplasma gondii infection in mice. Parasit Int. 2012; 61(3):481-486.

IssueVol 13 No 2 (2018) QRcode
SectionOriginal Article(s)
Neospora caninum Toxoplasma gondii AMA1 gene Recombinant adenovirus Immune response

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
JIA L, GUO H, LIU M, GAO Y, ZHANG L, LI H, XIE S, ZHANG N. Construction of an Adenovirus Vaccine Expressing the Cross-reactive Antigen AMA1 for Neospora caninum and Toxoplasma gondii and Its Immune Response in an Animal Model. Iran J Parasitol. 2018;13(2):235-243.